Garth Beinart MD in Houston, Texas

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: Baylor College Of Medicine
Graduation Year: 2001
The Primary Medical Specialty for Garth Beinart MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 23
PAC (PECOS ID)#: 5890733463
NPI #: 1396844262
NPI Created On: 09/21/2006
NPI Last Updated Listed as: 01/28/2016
Primary Taxonomy Code: 207RX0202X
License Number:
L7664
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Xhosa, Zhuang, Yiddish, Yoruba, Zerbaijani.

Services and Procedures include:

1. Routine ekg using at least 12 leads including interpretation and report
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
5. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
6. Infusion of chemotherapy into a vein up to 1 hour
7. Infusion of chemotherapy into a vein
8. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 10 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Established patient office or other outpatient, visit typically 40 minutes
14. Initial hospital inpatient care, typically 50 minutes per day
15. Subsequent hospital inpatient care, typically 15 minutes per day
16. Subsequent hospital inpatient care, typically 25 minutes per day
17. Subsequent hospital inpatient care, typically 35 minutes per day
18. Injection, denosumab, 1 mg
19. Injection, dexamethasone sodium phosphate, 1 mg
20. Injection, diphenhydramine hcl, up to 50 mg